Interfering with interferons in inflammatory bowel disease.
Ghosh
S
S
Gastrointestinal Section, Imperial College London, Hammersmith Hospital, London, UK. s.ghosh@imperial.ac.uk
Chaudhary
R
R
Carpani
M
M
Playford
R
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003424:Crohn Disease / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology; D007371:Interferon-gamma / Q000037:antagonists & inhibitors* / Q000276:immunology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C505731:fontolizumab; D007371:Interferon-gamma